Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial
<p>Abstract</p> <p>Background</p> <p>Gestational hypertension (GH) and pre-eclampsia (PE) can result in severe complications such as eclampsia, placental abruption, syndrome of Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) and ultimately even neonatal or m...
Những tác giả chính: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
BMC
2011-07-01
|
Loạt: | BMC Pregnancy and Childbirth |
Truy cập trực tuyến: | http://www.biomedcentral.com/1471-2393/11/50 |